Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

NCT00070564

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
View all 542 locations
View Trial Details
Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer

NCT05802225

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • JSC "Modern Medical Technologies" Saint Petersburg, Sankt-Peterburg, Russia
  • The Loginov Moscow Clinical Scientific Center MHD Moscow, Russia
  • Budgetary healthcare institution of the Omsk region "Clinical oncological dispensary" Omsk, Russia
View Trial Details
Active, Not Recruiting

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

NCT04915755

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • GSK Investigational Site Burbank, California, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Palo Alto, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 198 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

NCT03725059

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Southern Cancer Center, PC ( Site 8003) Daphne, Alabama, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center ( Site 0001) Goodyear, Arizona, United States
  • Arizona Oncology Associates PC- HOPE ( Site 8008) Tucson, Arizona, United States
  • Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0079) Los Angeles, California, United States
View all 244 locations
View Trial Details

Related conditions